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ABSTRACT Polyhydroxyalkanoates (PHAs) are biodegradable polyesters that accu-
mulate in the cytoplasm of certain bacteria. One promising biotechnological applica-
tion utilizes these biopolymers as supports for protein immobilization. Here, the
PHA-binding domain of the Pseudomonas putida KT2440 PhaF phasin (BioF polypep-
tide) was investigated as an affinity tag for the in vitro functionalization of poly-3-
hydroxybutyrate (PHB) particles with recombinant proteins, namely, full-length PhaF
and two fusion proteins tagged to BioF (BioF–C-LytA and BioF–-galactosidase, con-
taining the choline-binding module C-LytA and the -galactosidase enzyme, respec-
tively). The protein-biopolyester interaction was strong and stable at a wide range
of pHs and temperatures, and the bound protein was highly protected from self-
degradation, while the binding strength could be modulated by coating with amphi-
philic compounds. Finally, BioF–-galactosidase displayed very stable enzymatic ac-
tivity after several continuous activity-plus-washing cycles when immobilized in a
minibioreactor. Our results demonstrate the potentialities of PHA and the BioF tag
for the construction of novel bioactive materials.
IMPORTANCE Our results confirm the biotechnological potential of the BioF af-
finity tag as a versatile tool for functionalizing PHA supports with recombinant
proteins, leading to novel bioactive materials. The wide substrate range of the
BioF tag presumably enables protein immobilization in vitro of virtually all natu-
ral PHAs as well as blends, copolymers, or artificial chemically modified deriva-
tives with novel physicochemical properties. Moreover, the strength of protein
adsorption may be easily modulated by varying the coating of the support, pro-
viding new perspectives for the engineering of bioactive materials that require a
tight control of protein loading.
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The immobilization of peptides and proteins on polymer surfaces to develop bio-active supports represents a challenging goal in biotechnology and biomedicine (1,
2). As more biotechnologically relevant materials with new properties are described,
novel methods for efficient protein functionalization are also required. Among the
immobilization procedures, covalent methods ensure the strongest binding to the
support, providing, in some cases, even more stability to the immobilized protein.
However, the matrix is barely recoverable after enzyme inactivation, and these methods
normally require the use of chemical-linking reagents that might perturb the native
structure of the polypeptide (although interesting, alternative in situ systems have been
recently described) (3). On the other hand, noncovalent methods are generally of a
weaker intensity but have other important advantages, as they are normally simple and
gentle and do not require the chemical modification of the protein, thus diminishing
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the risk of denaturation. In addition, immobilization is reversible in most cases, enabling
the straightforward regeneration of the support (4, 5).
Current trends in material research specifically focus on biocompatible and biode-
gradable, yet versatile and stable, supports. The polyhydroxyalkanoate (PHA) family
possesses all these characteristics. PHAs are natural polyesters of 3-hydroxyalkanoic
acids that accumulate intracellularly in several organisms as a reserve material. They
possess a high variety of monomer compositions, providing them with different
physicochemical properties and functionalities (6–9). Depending on the length of the
carbon chain, PHAs are classified as (i) short-chain-length PHAs (scl-PHAs; 3 to 5 carbon
atoms), (ii) medium-chain-length PHAs (mcl-PHAs; 6 to 14 carbon atoms), or (iii)
long-chain-length PHAs (lcl-PHAs; more than 14 carbon atoms) (10). The scl-PHA
poly-3-hydroxybutyrate (PHB) represents the most produced and commercially suc-
cessful member of the PHA family (11, 12). The PHAs constitute, among natural
polymers, the largest group of microbial polyesters that displays thermoplastic features
(9, 13) (hence the commonly used term “bioplastics”). They have been hailed as
potential competitors of oil-derived plastics, not only because of their physical prop-
erties but also for their biocompatibility and biodegradability (8, 14, 15) and the high
sustainability of their sources, as they naturally accumulate as a reserve material in
several microbial (16) and engineered plant (17) species. The tunable structural features
of these polyesters based on their variable compositions make them highly attractive
for the development of next-generation biomaterials capable of being functionalized
with peptides and proteins.
Native PHA granules are subcellular structures formed by a polymeric core sur-
rounded by granule-associated proteins (GAPs) (18). Microbial PHA preparations usually
contain adsorbed phospholipids as well (19), although the actual occurrence of this
coating in vivo has been recently questioned and might represent a purification artifact
from the cell extracts (20–22). Phasins, the main component of GAPs, have a relevant
role in the PHA intracellular metabolism, participating in events that include the control
of the size, number, and localization of granules in the cell (23, 24). The high affinity of
phasins for PHA suggests the application of such polypeptides as affinity tags for the
immobilization of proteins on polyester granules. Despite its potential, only a few
examples of phasin-mediated immobilization of recombinant proteins have been
described to date (25–31). In particular, Prieto and coworkers (32) developed the BioF
tag derived from the PHA-binding domain of the PhaF phasin from Pseudomonas putida
KT2440, a protein that is involved in the intracellular stabilization and localization of the
PHA granule as well as in its equal distribution between daughter cells upon cell
division, due to the presence of a DNA-binding domain (33, 34). Several fusion proteins
containing the BioF sequence were expressed and found to be associated in vivo with
native mcl-PHA granules in P. putida without compromising its functionality (32). The
fusion proteins could be recovered from the granules by a mild treatment with
detergents. In a step toward effective biotechnological applications, native granules
containing a variant of the Cry1Ab toxin with insecticidal properties were produced
(35), demonstrating that the functionalization of PHA polyesters with BioF-tagged
proteins constitutes a promising field for designing bioactive polymers of interest.
However, several aspects of these in vivo systems need be addressed for their successful
application, such as the control of granule size and the amount of immobilized protein,
as well as the overall conditions of the environment regulating its binding (pH,
temperature, etc.).
To date, most studies have dealt with the interaction between a particular PHA and
the cognate phasin with which it naturally interacts in vivo, but the peculiar organiza-
tion of phasins as predominantly amphipathic -helical proteins that recognize the
biopolymer through relatively nonspecific interactions (23) enables speculation on the
possibility of a wider PHA substrate range for this family of polypeptides. It is also
evident that a single versatile tag able to recognize different types of PHAs would imply
an important biotechnological capacity. Therefore, we decided to characterize the
binding of several BioF fusions to scl-PHA particles such as PHB. Although several
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phasins naturally bound to PHB inclusions have been described (23, 24), our
approach considered the aim of expanding the applications of the BioF tag (a
naturally mcl-PHA-binding polypeptide) rather than finding a strong tag strictly
recognizing a particular PHA. Furthermore, we have assessed the functional per-
formance of a BioF–-galactosidase hybrid protein immobilized on PHB as a proof
of concept for the development of PHA-based enzymatic bioreactors. We believe
that our results confirm that BioF-based PHA functionalization procedures possess
an evident potential in biomedicine and bioprocess technology.
RESULTS
In vitro interaction of the PhaF phasin with lipid/GAP-free PHB particles. The
binding capability of the BioF polypeptide to mcl-PHA granules has been widely
demonstrated in vivo (32, 35, 36). Nevertheless, native PHA granules are surface coated
by several GAPs and probably by a lipid layer that might interfere with the BioF binding
in vivo. Therefore, in a first approach, we tested the ability of the entire PhaF phasin to
be immobilized in vitro on commercially available PHB particles devoid of any protein
or lipid coating. Figure 1 shows that, in sodium phosphate (PNa) buffer at 25°C or 37°C,
PhaF could be clearly adsorbed on PHB, indicating that the substrate range of the BioF
tag also includes scl-PHAs and that no other granule-associated components are
needed for efficient binding.
The stability of this PhaF-PHB interaction was evaluated at both 25 and 37°C. After
48 h of incubation, approximately 65% of the initially added PhaF (representing 75% of
the initially bound protein) remained stably attached to the polyester at both temper-
atures without significant hints of protein degradation (Fig. 1). Furthermore, incubation
at pHs other than 7.0 did not appear to have a direct influence on immobilization, as
the protein remained similarly adsorbed to the particles in all cases (see Fig. S3 in the
FIG 1 (Left) Stability of PhaF binding to PHB at 25 and 37°C analyzed by SDS-PAGE. C, control of soluble protein;
B, bound protein eluted from PHB with 1% (wt/vol) SDS after heating at 90°C for 10 min. (Right) Results of gel
densitometry, shown as the percentages of the initial applied protein. Black solid bars indicate soluble control
protein, whereas red hashed bars represent the particle-bound protein.
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supplemental material). This result supports the hypothesis that ionic forces are minor
contributors to PHA recognition (34). To test the strength of the hydrophobic interac-
tions, protein desorption was induced by incubations with several detergents at 25°C
(Fig. 2A; see also Fig. S4). PhaF was eluted from the polymer particles with the greatest
efficiency by SDS and sarcosyl, and only partially (18%) with Tween 20 (Fig. 2A).
However, other detergents such as Triton X-100, 3-[(3-cholamidopropyl)-dimethyl-
ammonio]-1-propanesulfonate (CHAPS), and sodium cholate were unable to desorb the
protein at the concentrations tested (Fig. 2A).
The affinity of PhaF to PHB was also quantified by a Langmuir analysis (Fig. 3). The
binding isotherm acquired at 25°C reveals a maximum loading capacity of 20  2 g
PhaF/mg PHB and a dissociation constant of 0.5  0.1 mg/ml (18.3 M) (Table 1). These
values are similar to those from other PHA-binding proteins (37).
PHB coating interferes with PhaF binding. The mainly hydrophobic nature of the
phasin-PHA binding interaction makes it interesting to evaluate the effect of covering
the polyester with amphipathic compounds on the stability of PhaF adsorption. First,
commercially available PHB particles were coated with oleic acid (PHBOL particles), a
common component in artificial PHA preparations (38). Remarkably, the oleate cover
FIG 2 Elution of PhaF from different preparations of PHB upon incubation with detergents and the dependence on granule
coating. (Left panel) SDS-PAGE analysis. C, control of soluble protein; SDS, 1% (wt/vol) SDS; Tr, 1% (vol/vol) Triton X-100; Tw,
1% (wt/vol) Tween 20; Ch, 3% (wt/vol) CHAPS; Co, 3% (wt/vol) sodium cholate; Sc, 3% (wt/vol) sarcosyl. (A) Naked PHB; (B) PHB
coated with sodium oleate (PHBOL); (C) PHB coated with phosphatidylglycerol and phosphatidylcholine (PHBPL). (Right panel)
Quantification of elution efficiency by gel densitometry.
FIG 3 Analysis of the saturation capacity of PHB preparations by Langmuir isotherm analysis. Each point
in the plot represents the mean from three independent experiments.
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somehow increases the affinity for PhaF, while significantly augmenting its maximum
binding capacity (Table 1 and Fig. 3). This may be explained in terms of a specific
stabilizing interaction between oleate molecules and PhaF that has been described
before (34). Nevertheless, and for the same reason, the PhaF-loaded PHBOL particles
were more sensitive to competing detergents whose structures mimic that of oleate
(i.e., long hydrocarbon chains), namely, Triton X-100 and especially Tween 20 (Fig. 2B;
see also Fig. S4). Finally, with the aim of mimicking the lipid layer inherently found in
usual PHA preparations, PHB granules were coated with a 1:1 (wt/wt) lipid mixture of
phosphatidylcholine and phosphatidylglycerol (PHBPL particles). In this case, the affin-
ity for PhaF was severely diminished (Table 1 and Fig. 3), and the protein could be
eluted with an appreciable yield by all tested detergents except CHAPS (Fig. 2C). To
check for any possible destabilizing effect on the PHB particle caused by the phospho-
lipid layer, we evaluated the aspect, stability, and degree of crystallinity of both
lipid-treated and nontreated PHB materials by differential scanning calorimetry (DSC)
and scanning electron microscopy (SEM). Figure 4 and Table 2 show that the size and
morphology of PHB granules did not appreciably change upon coating. Data in Table
2 also indicate that lipid coating produced only a moderate decrease in crystallinity
(65% to 44%), even after the lyophilization step, while thermal stability and particle size
were also largely unaffected. These results demonstrate that granule coatings by
amphiphilic compounds affect the BioF-PHB interaction to variable extents without
substantially affecting particle integrity.
Immobilization of BioF-tagged hybrid proteins on PHB. The results shown so far
indicate that the PhaF phasin is likely to bind to different types of PHAs, such as PHB.
This adds a novel functionality for the BioF polypeptide to serve as a versatile affinity
tag for anchoring recombinant proteins of interest to a wide range of polyhydroxyal-
kanoates. To further evaluate the biotechnological potential of this result, we analyzed
the in vitro binding of the BioF–C-LytA protein (formerly named FLyt), a fusion of BioF
TABLE 1 Binding properties of PHB preparations for PhaFa
Material
qmax (g protein/
mg PHB) Kd (mg/ml)
PHB 20  2 0.5  0.1
PHBOL 35  3 0.4  0.1
PHBPL 24  4 1.0  0.4
aCalculated by Langmuir analysis (see Materials and Methods for the equation and Fig. 3).
FIG 4 SEM micrographs of PHB and PHBPL preparations.
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with the C-LytA choline-binding module (32), to synthetic PHB granules. Only the
binding of BioF–C-LytA to native mcl-PHA granules in vivo had been previously studied
(32). As shown in Fig. 5, purified BioF–C-LytA was able to bind to PHB at 37°C with an
affinity comparable to that of the PhaF phasin (77% of applied protein, see Fig. 1) and
also independently of pH and ionic strength (data not shown). The stability against
detergents followed a trend similar to that for PhaF, with sarcosyl and SDS being the
most efficient eluting agents (see Fig. S5). Unexpectedly, the residual elution capability
of Tween 20 for PhaF was not detected in the case of BioF–C-LytA. Nevertheless, this
effect might be ascribed to secondary interactions taking place between the polymer
and the relatively hydrophobic aromatic-rich C-LytA moiety (39) that is likely to
strengthen the binding. On the other hand, in contrast to the PhaF case (Fig. 2), CHAPS
was able to elute a small but detectable amount of BioF–C-LytA protein (Fig. S5). This
is probably due to the fact that the quaternary ammonium group in the detergent (Fig.
S4) may act as a specific choline-like ligand of the C-LytA moiety (40) and helps release
the protein from the polymer. Importantly, while BioF–C-LytA is unstable in solution
and shows evident signs of autodegradation at 37°C, a clear protective effect provided
by the PHB matrix is evident when the protein is immobilized on the polymer (Fig. 5).
Construction of PHB-based enzymatic minibioreactors. Once the capability and
functionality of the BioF tag as an immobilization system of fusion proteins to com-
mercial preparations of PHB were confirmed, we evaluated the possibility of using this
platform for the construction of enzyme bioreactors. As a proof of concept, we assessed
the performance of the hybrid protein BioF–-galactosidase (formerly named FLac) in
a PHB-based minibioreactor, where the BioF polypeptide is fused to the Escherichia coli
-galactosidase protein (32). Even though the BioF–-galactosidase enzyme could only
be purified to approximately 35% (Fig. S2), it still represents a suitable system, since the
majority of industrial applications involving immobilized enzymes do not require a
greater extent of protein purity (41). The partially purified BioF–-galactosidase prep-
TABLE 2 Calorimetric characterization of PHB preparations







PHB 173.3  0.9 95  3 65 20.0 0.5–1
PHBPL 173.0  0.9 70  20 44 25.5 0.3–0.9
aTm, melting temperature.
bΔHm, melting enthalpy.
cCalculated according to reference 53.
dBy SEM.
FIG 5 (Left) Analysis by SDS-PAGE of the stability of BioF–C-LytA binding to PHB at 37°C. C, control of soluble protein; B, bound
protein eluted from PHB with 1% (wt/vol) SDS after heating at 90°C for 10 min. Black arrows indicate degradation fragments
of BioF–C-LytA in solution. (Right) Results of gel densitometry, shown as percentages of initial applied protein.
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aration was adsorbed on PHB, and the enzymatic activity was assayed in 14 reaction/
washing cycles (10 min each), followed by two other cycles assayed after 48 and 96 h
(Fig. 6). After such incubations, the enzymatic activity was still conserved at 75%  7%
with respect to the initial activity, suggesting that the enzyme kept its stability under
these conditions and that protein desorption from the matrix was not relevant.
DISCUSSION
Polyhydroxyalkanoate-based technologies based on functionalization with proteins
possess a high biotechnological potential that, nevertheless, has not yet found the
expected industrial development and application. These limitations are particularly
linked with the restrictions of the production systems. Therefore, to achieve a wide
industrial application and performance comparable to those of other commercially
available polymers, improved PHA-based protein immobilization platforms need to be
developed (42). Moreover, the need for high-added-value applications and particularly
the construction of bioactive PHA supports by means of protein functionalization might
boost the commercial importance of PHA. Nevertheless, the construction of bioactive
PHA systems by protein immobilization has been investigated to a limited degree at the
laboratory scale and is still a nascent technology that needs scaling up for industrial
applications (43). Very efficient covalent methods for PHA functionalization-based
translational fusions with PhaC from Ralstonia eutropha have been described in detail
by Rehm’s group, leading to a variety of biotechnological and biomedical applications
(3, 44, 45). However, in the case of noncovalent methods like those based in phasins,
several key technical issues, such as control of PHA-protein association/dissociation and
granule size, still remain unresolved.
Herein, we have evaluated the in vitro binding properties of the PHA-binding
domain of the PhaF phasin from P. putida KT2440 (BioF tag) to scl-PHAs such as PHB
particles devoid of any coating. The BioF-PHB interaction is very stable with respect to
temperature (25 to 37°C) (Fig. 1), time (48 to 96 h) (Fig. 1, 5, and 6), pH (2 to 9) (Fig. S3
in the supplemental material), and detergent action (Fig. 2). Similar results were
obtained with the fusion protein BioF–C-LytA (Fig. 5; see also Fig. S5), demonstrating
that binding to PHB is mostly ascribed to the BioF sequence independently of the fused
polypeptide. Furthermore, the binding of the fusion protein to PHA may strongly
protect the adsorbed protein from degradation, as revealed for BioF–C-LytA (Fig. 5). Our
results indicate that the BioF tag is especially suited to provide a robust and stable, yet
straightforward, protein immobilization platform not only to its natural cognate mcl-
PHA substrate but also to commercially available PHB and, probably, to many other
PHA types. To date, only limited examples of phasin binding to pure noncoated PHA
FIG 6 Activity of PHB-immobilized BioF–-galactosidase during 16 continuous cycles. Time between
cycles was 20 min, except for cycles 15 and 16, which were carried out after 48 and 96 h, respectively.
Each experiment represents the mean from six determinations.
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preparations have been reported (30, 46). However, more studies of this kind are
necessary, since several applications, especially in the biomedical field, require homo-
geneous materials free of endotoxins or other incompatible components.
The molecular nature of the binding between BioF and mcl-PHAs is likely to be
mainly based on hydrophobic, nonspecific interactions, according to the predicted
secondary structure of the PhaF phasin (34). This structural model predicts that the BioF
sequence folds into a long, tetrameric amphipathic -helix that recognizes the surface
of the PHA granule through the nonpolar face of the helix. As expected for a mainly
hydrophobic interaction, the BioF-PHB binding is susceptible to detergent treatment.
The efficiency of the detergent treatment strongly depends on the detergent type. The
agents with the highest eluting performances are SDS and sarcosyl (Fig. 2; see also Fig.
S5), which is in agreement with similar in vivo results when mcl-PHAs have been used
as the immobilization substrate (32). Therefore, these should be the compounds of
choice to eventually regenerate the PHB support in any biotechnological process that
requires a new loading with fresh protein. Moreover, SDS and sarcosyl are also the
detergents with the longest linear hydrocarbon moieties (Fig. S4), which are likely to
better intercalate within the presumably elongated BioF-PHA interface (34). While
Tween 20 also has a long linear hydrophobic chain, its polar moiety is sizeable, probably
hampering the interaction with the hydrophobic side of the helix (Fig. S4). Conse-
quently, this detergent displays an intermediate eluting behavior that is enhanced
when the protein-granule interaction is weakened upon granule coating (Fig. 2). Finally,
Triton X-100 and sodium cholate possess the shortest linear chains and subsequently
show the poorest elution properties. CHAPS represents a peculiar case, because its
structure is devoid of linear chains and, accordingly, does not elute PhaF from the PHB
granule (Fig. 2). However, the binding of the BioF–C-LytA chimera is somehow suscep-
tible to this detergent both in vitro (Fig. S5) and in vivo (32), probably because CHAPS
behaves as a ligand of the C-LytA moiety and helps elute the protein by weakening a
secondary non-BioF-related interaction. This indicates that the polypeptide fused to the
BioF tag may also contribute, positively or negatively, to strength of the binding to PHA.
The BioF-PHB interaction is affected if the polyester is coated in vitro with amphi-
philic compounds such as oleic acid and, especially, phospholipid layers (Fig. 2 and 3;
Table 1). This dependence on granule coating has also been observed for the binding
of the PhaP phasin from Ralstonia eutropha to polyhydroxyoctanoate surfaces, which
was prevented by the presence of a phospholipid cover in the granule (46). Given its
elongated shape, BioF is likely to be attached to the PHA polymer in parallel with its
surface (34) but not deeply penetrating into the granule, as this would certainly impose
an excessive desolvation energy penalty to the polar residues in the hydrophilic face of
the helix. Hence, it is not surprising that any coating of the matrix should affect the
direct association between the affinity tag and the polyester by decreasing the amount
of available PHB surface. Far from constituting a drawback, this dependence on coating
represents a useful characteristic to rationally modulate the strength of BioF-tagged
protein adsorption and may find its application in processes requiring a fine tuning of
the interactions, such as the controlled release of therapeutic proteins and peptides (47,
48) or the straightforward regeneration of enzymatic reactors after enzyme inactivation.
To date, the main applications of protein-functionalized PHAs have been aimed at
biomedical purposes, such as diagnosis, vaccines, drug delivery, and cell imaging (42).
However, the development of PHA-based enzymatic reactors has been analyzed to a
very limited degree. Therefore, in this work, we have studied the enzymatic activity of
the chimeric protein BioF–-galactosidase immobilized on PHB particles as a proof of
concept for the construction of these systems. Our procedure led to systems showing
stable galactosidase activity during several continuous cycles of reaction/washing as
well as an extended enzyme performance (at least 96 h) (Fig. 6). These results confirm
the strong interaction between the BioF tag and PHB particles and pave the way for the
construction of sustainable reusable PHA supports designed for enzymatic biotransfor-
mations.
Bello-Gil et al. Applied and Environmental Microbiology
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MATERIALS AND METHODS
Bacterial strains, plasmids, and general growth conditions. Liquid cultures of Escherichia coli were
grown at 37°C in Luria-Bertani (LB) broth (49) supplemented with kanamycin (0.05 mg/ml) or strepto-
mycin (0.05 mg/ml), depending on the plasmid resistance, in an orbital shaker (200 rpm; INNOVA 4000).
Bacterial growth was followed by turbidimetry at 600 nm using an Evolution 201 spectrophotometer
(Thermo Scientific).
Overproduction and purification of recombinant proteins. As a general procedure, overexpres-
sion was carried out in every case in freshly transformed cells with the corresponding expression vector
according to CaCl2 transformation protocols (49). The purity of protein preparations was checked by
polyacrylamide gel electrophoresis under denaturing conditions (SDS-PAGE) (50) using the Mini-Protean
systems from Bio-Rad. Gels were stained with EZBlue (Sigma-Aldrich). The concentration of pure proteins
was assessed by absorption spectroscopy at 280 nm (Evolution 201; Thermo Scientific) with theoretical
molar extinction coefficients of 19,071 M1 · cm1 (PhaF) and 109,320 M1 · cm1 (BioF–C-LytA) using
the online software ProtParam from the ExPASy toolbox (http://web.expasy.org/protparam). Samples
containing partially purified BioF–-galactosidase were quantified by using the protein assay dye reagent
concentrate from Bio-Rad and bovine serum albumin (Sigma-Aldrich) as the standard. Enzyme fractions
were stored at 20°C until further use.
PhaF protein was overexpressed in E. coli BL21(DE3) cells harboring the pETPhaF plasmid and purified
by hydrophobic interaction chromatography on butyl-Sepharose (GE Healthcare) as previously described
(33).
For the purification of the Bio–C-LytA protein, E. coli CC118 cells harboring plasmid pNFA2 (32) were
grown at 37°C and 200 rpm until the culture reached an optical density at 600 nm (OD600) of 0.6. Then,
FLyt gene overexpression was induced for 14 h at 30°C by the addition of 0.5 mM isopropyl -D-1-
thiogalactopyranoside (IPTG). Cells were harvested by centrifugation at 4°C (10,000  g), resuspended in
20 mM sodium phosphate (PNa) buffer (pH 7.0) plus 100 mM NaCl (50 ml per liter of culture), disrupted
by sonication (Branson 250), and centrifuged again for 10 min at 4°C (10,000  g). Insoluble inclusion
bodies containing denatured BioF–C-LytA were redissolved in 8 M urea (25 ml per liter of culture),
followed by centrifugation for 10 min at 4°C (10,000  g). Simultaneous refolding and purification of
BioF–C-LytA were accomplished in one step by directly loading the supernatant onto a Sephadex G-100
gel filtration column (50 cm by 1 cm; Bio-Rad), employing PNa buffer plus 100 mM NaCl as the mobile
phase. Fractions with more than 90% purity, as assessed by SDS-PAGE, were stored at 4°C (Fig. S1 in the
supplemental material).
The purification of the BioF–-galactosidase fusion was accomplished by using E. coli CC118 cells
harboring plasmid pNFL2 (32) grown and processed as for the BioF–C-LytA protein (see above), except
that BioF–-galactosidase protein was found predominantly in the soluble fraction after sonication.
Ammonium sulfate was slowly added at 4°C with stirring to a final concentration of 1.7 M, and the
solution was then centrifuged at 4°C (10,000  g) and the supernatant was applied to a butyl Sepharose
4 fast flow column (GE Healthcare) (10 cm by 1 cm) previously equilibrated with PNa buffer containing
1.7 M ammonium sulfate. The column was thoroughly washed with PNa buffer plus 0.75 M ammonium
sulfate, and then BioF–-galactosidase was finally eluted with PNa buffer. The result of the partial
purification is shown in Fig. S2, and the amount of BioF–-galactosidase with respect to the total protein
was estimated at 35%  3% upon gel densitometry using ImageJ (51). Attempts to further purify the
protein were unsuccessful in our hands.
Preparation and characterization of coated PHB particles. Artificial oleate-coated PHB granules
(PHBOL) were prepared by the oil-in-water emulsion method as previously described (38). Artificial
phospholipid-coated PHB granules (PHBPL) were prepared according to a previously described proce-
dure (52) with minor modifications. First, 1 volume of 5% (wt/vol) PHB (Sigma-Aldrich) solution in
chloroform was emulsified with 20 volumes of an aqueous solution of 2% (wt/vol) sodium cholate
(Sigma-Aldrich) by ultrasonication (20 kHz, 1 to 3 min). Then, chloroform was removed from the emulsion
under vacuum conditions (40°C for 60 min), and the artificial granules coated with sodium cholate were
harvested by centrifugation (10,000  g for 10 min) and washed twice with equal volumes of distilled
water. Granules were resuspended with equal volumes of PNa buffer containing L--phosphatidyl-D-L-
glycerol (5 mg/ml; Sigma-Aldrich) and L--phosphatidylcholine (5 mg/ml; Sigma-Aldrich) from egg yolk
previously emulsified by sonication in an aqueous solution of 2% (wt/vol) sodium cholate. The resulting
mixture was extensively dialyzed in 20 mM PNa buffer (pH 7.0) containing 25 g/liter Amberlite XAD-2
(Sigma-Aldrich) to remove sodium cholate. Finally, artificial phospholipid-coated PHB granules were
concentrated by lyophilizing to dryness (Telstar Cryodos).
The characterization of the PHB material was achieved by thermal analysis. Samples of approximately
5 to 10 mg were placed in an aluminum capsule and subjected to differential scanning calorimetry (DSC)
on a Pyris Diamond DSC calorimeter (PerkinElmer, Waltham, MA). The samples were heated under a
nitrogen atmosphere from 20°C to 200°C at a rate of 20°C/min. The degree of crystallinity was estimated
from the experimental melting enthalpies (ΔHm) assuming a value of 146 J/g for a 100% crystalline PHB
(53). PHB particles were also analyzed by scanning electron microscopy (SEM) in a Phenom-World ProX
microscope operating at 10 kV. Samples were placed in the microscope plate and sputter coated with
gold to ensure electrical conductivity. Both SEM and DSC analyses were carried out in the Plastics
Technology Centre AIMPLAS (Valencia, Spain).
Protein binding to PHB particles. As a general methodology, 5-mg amounts from different
preparations of PHB (PHB, PHBPL, or PHBOL) were incubated for 15 min with 20 to 30 g of a
BioF-containing protein (PhaF or BioF–C-LytA) in a final volume of 100 l PNa buffer at a temperature of
25 or 37°C. After mild mixing on a digital rotary mixer (Ovan), the unbound protein fraction was
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separated from the polyester by centrifugation (10 min at 10,000  g). PHB beads were washed five times
with 500 l PNa buffer plus 0.1 M NaCl and finally resuspended in 100 l of PNa buffer. To check the
strength of the protein-PHB interaction, the resuspension buffer contained the corresponding deter-
gents: 1% (wt/vol) SDS, 3% (wt/vol) sarcosyl, 1% (wt/vol) Tween 20, 1% (vol/vol) Triton X-100, 3% (wt/vol)
sodium cholate, and 3% (wt/vol) CHAPS (Sigma-Aldrich). After 15 min of incubation at 25°C, samples
were centrifuged and the eluted protein fractions were analyzed by UV spectroscopy and SDS-PAGE.
To determine the affinity of the protein-PHB interaction and the maximum protein binding capacity
by Langmuir analysis (54, 55), 10 mg of PHB was incubated with increasing concentrations of PhaF (0 to
2.5 mg/ml) in PNa buffer (500 l). After mild mixing (30 min at 25°C) on a digital rotary mixer (Ovan), the
unbound protein fraction was recovered from the polyester by centrifugation (10 min at 10,000  g). The
amount of PhaF bound to PHB (g PhaF/mg PHB) was calculated by subtracting the unbound protein
from the initial added protein. Data were fitted to the equation q  (qmaxC)/(Kd  C) (54, 55), where q
is the amount of protein bound on PHB (g protein/mg PHB), qmax is the maximum adsorption capacity
of PHB granules (g protein/mg PHB), C is the concentration of protein added (mg/ml), and Kd is the
dissociation constant (mg/ml).
-Galactosidase enzyme activity. The -galactosidase activity of the immobilized hybrid BioF–-
galactosidase protein was assayed spectrophotometrically according to Miller (56). BioF–-galactosidase
(approximately 2.5 g, as estimated by gel densitometry [see above]) was first immobilized on 0.5 mg
of PHB as described above for PhaF. After extensive washing with PNa buffer, the resin was incubated
for 10 min at 25°C with 5 mM o-nitro-phenyl--D-galactopyranoside (ONPG) on a digital rotary mixer
(Ovan). We previously checked that the enzymatic reaction was linear within these time limits (data not
shown). The sample was then briefly centrifuged (10,000  g), the supernatant was removed, and the
reaction was stopped with 0.12 M Na2CO3. Enzymatic activity was assessed following the formation of
o-nitrophenol at 420 nm (420  4,500 M1 · cm1), after subtracting a blank that was processed the
same way but without the enzyme added. The remaining PHB support was extensively washed with PNa
buffer to remove remaining traces of ONPG and o-nitrophenol and subjected to new enzymatic cycles
by the addition of fresh 5 mM ONPG.
SUPPLEMENTAL MATERIAL
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